A research paper on 3billion's automated variant prioritization system, EVIDENCE, published in Wiley's Clinical Genetics Journal in December 2020, was selected as the ‘Top Cited Article’ during 2020-2021.

This announcement made it clear that the industry is paying attention to automated variant analysis technology of 3billion.

3billion recognized that the existing manual variant prioritization method was time-consuming and inefficient and sometimes involved interpreters’ subjective judgment. Thereby, in 2019, 3billion developed an ‘EVIDENCE system’ that complies with ACMG guidelines while enabling consistent and rapid interpretation, and is actively using it for diagnosis.

Pay attention to 3billion's variant prioritization and variant prediction technology. We will continue making progress in the future.

Want to learn more about 3billion's technology?

Get the whitepaper now

Do you want to keep up with the latest post of this series?